Mankind Pharma's Stock Reaches 52-Week High, Outperforms Market with Strong Growth
Mankind Pharma, a leading pharmaceutical company in India, has reached a new milestone as its stock price hit a 52-week high on October 14, 2024. The company's stock is currently rated as 'Hold' by MarketsMojo and has outperformed the market in the past year with a growth of 54.23%. With a strong product range and distribution network, Mankind Pharma is poised for continued success in the Indian pharmaceutical industry.
Mankind Pharma, a leading pharmaceutical company in India, has recently reached a new milestone as its stock price touched a 52-week high on October 14, 2024. The company, which is classified as a largecap in the pharmaceutical and drugs industry, has been performing well in the market.
According to MarketsMOJO, a leading stock market analysis and research platform, the current stock call for Mankind Pharma is 'Hold'. The company's stock price has reached a new high of Rs. 2839, which is also an all-time high for the company.
In terms of performance, Mankind Pharma has underperformed the sector by -1.05% today. However, the company's stock is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
In the past year, Mankind Pharma has shown a strong performance with a growth of 54.23%, while the Sensex has only grown by 23.24%. This showcases the company's ability to outperform the market and deliver value to its investors.
Mankind Pharma has established itself as a key player in the Indian pharmaceutical industry with a wide range of products and a strong distribution network. With its consistent growth and positive market performance, the company is poised for further success in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
